Fields of research
Appropriate inflammatory response efficiently participates in the organismal protection against infections and mediates tissue repair following injuries. Adversely chronic or excessive inflammation is detrimental upon sepsis and fuels pathogenesis of a large set of highly prevalent multifactorial conditions including Alzheimer’s disease, type 2 diabetes, atherosclerosis and cancer. Our objective is to decipher the molecular mechanisms controlling inflammation, in order to propose innovative therapeutics against these diseases as well as to improve their diagnosis and prevention.
At the molecular level, inflammation is triggered by a battery of receptors recognizing molecular structures specific to microorganisms (PAMP, pathogen-associated molecular pattern) or signals resulting from cellular damage and metabolic stress (DAMP, damage-associated molecular pattern). These receptors are highly diverse in their specificities, subcellular localizations and downstream signaling pathways, and constitute a network able to trigger an appropriate response to a large variety of insults.
Our research focuses on NLRP3, a cytosolic receptor involved in the response to all kinds of pathogens (virus, bacteria, fungi and parasites) but also in deleterious inflammation associated to numerous human pathologies including Gout arthritis, Alzheimer’s disease, type 2 diabetes and atherosclerosis. Low-grade NLRP3-mediated inflammation participates in age-related functional decline. In addition, mutations in NLRP3 gene cause hereditary autoinflammatory syndrome. Therefore, NLRP3 is particularly relevant in regards to multiple highly prevalent conditions.
Upon activation, NLRP3 assembles an oligomeric complex named inflammasome, serving as an activation platform for caspase-1. Caspase-1 protease then controls maturation and secretion of key proinflammatory cytokines, and can trigger a proinflammatory form of cell death named pyroptosis.
NLRP3 does not directly bind its diverse activators and we still know very little about the molecular mechanism of NLRP3 activation. Using a pharmacological approach, we recently discovered that inflammasome assembly is regulated by NLRP3 post-translational modifications. Our research combines biochemistry and cell biology approaches with analysis of transgenic mouse models and patients studies in order to get a better understanding of NLRP3 activation mechanism.